Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) EBT Margin (2020 - 2022)

Historic EBT Margin for Therapeutics (RAPT) over the last 3 years, with Q2 2022 value amounting to 2134.2%.

  • Therapeutics' EBT Margin fell 2803400.0% to 2134.2% in Q2 2022 from the same period last year, while for Mar 2023 it was 10900.68%, marking a year-over-year decrease of 86275600.0%. This contributed to the annual value of 5618.53% for FY2022, which is 38035800.0% down from last year.
  • As of Q2 2022, Therapeutics' EBT Margin stood at 2134.2%, which was down 2803400.0% from 3241.34% recorded in Q1 2022.
  • Therapeutics' 5-year EBT Margin high stood at 938.74% for Q3 2020, and its period low was 3241.34% during Q1 2022.
  • In the last 3 years, Therapeutics' EBT Margin had a median value of 1616.87% in 2020 and averaged 1711.37%.
  • Its EBT Margin has fluctuated over the past 5 years, first soared by 285000bps in 2021, then crashed by -18899500bps in 2022.
  • Quarter analysis of 3 years shows Therapeutics' EBT Margin stood at 962.83% in 2020, then plummeted by -146bps to 2371.56% in 2021, then rose by 10bps to 2134.2% in 2022.
  • Its EBT Margin stands at 2134.2% for Q2 2022, versus 3241.34% for Q1 2022 and 2371.56% for Q4 2021.